I agree that not making a deal on HerVaxx was in error, but we...

I agree that not making a deal on HerVaxx was in error, but we will never know the reason why it didn’t occur, perhaps an offer that was too lowball that it was considered offensive?
The current tech, if proven up, surpasses anything that HerVaxx could have provided.
Hypothetically, they could have sold HerVaxx but come up with a superior product not too soon after, pretty sure that scenario would have severely impacted any relationship with any BP suitor.
As for AzerCell, I don’t see it as a replacement for our current tech, but more to compliment it.
All will be revealed over time, just depends on if you are prepared to wait.
Also, IMO anyone investing an amount that makes them feel uncomfortable, needs to reconsider their decisions.
It’s been a long game admittedly, and I certainly have been in for longer than I would have liked, but when I doubt my decision, I think back to LC saying something along the lines of … the data is the most impressive she has ever seen … and if she has been misleading, she’s certainly be liable.
Not investment advice, but I’m in for the long haul and topping up periodically. I’ll be reassessing this time next year.